Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / Fund iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker DRDR(GBX) LSE
ETF Ticker 2B78(EUR) F
ETF Ticker 2B78.DE(EUR) CXE
ETF Ticker DRDR.LS(GBX) CXE
ETF Ticker HEAL.AS(EUR) CXE
ETF Ticker HEAL.LS(USD) CXE
ETF Ticker HEALz(USD) CXE
ETF Ticker HEAL(EUR) ETF Plus
ETF Ticker DRDR.L(GBP) LSE

Holdings detail for EW

Stock Name	Edwards Lifesciences Corp
Ticker	EW(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US28176E1082
LEI	YA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen: Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings: Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab: Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW): Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research: Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00: Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW): J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW): Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC: Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW): Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares Healthcare Innovation UCITS ETF USD (Acc) EW holdings

Date	Number of EW Shares Held	Base Market Value of EW Shares	Local Market Value of EW Shares	Change in EW Base Value	Current Price per EW Share Held	Previous Price per EW Share Held
2025-11-11 (Tuesday)	197,609	USD 16,828,382	USD 16,828,382	USD 213,417	USD 85.16	USD 84.08
2025-11-10 (Monday)	197,609	USD 16,614,965	USD 16,614,965	USD 136,350	USD 84.08	USD 83.39
2025-11-07 (Friday)	197,609	USD 16,478,615	USD 16,478,615	USD 187,729	USD 83.39	USD 82.44
2025-11-06 (Thursday)	197,609	USD 16,290,886	USD 16,290,886	USD -79,044	USD 82.44	USD 82.84
2025-11-05 (Wednesday)	197,609	USD 16,369,930	USD 16,369,930	USD -258,867	USD 82.84	USD 84.15
2025-11-04 (Tuesday)	197,609	USD 16,628,797	USD 16,628,797	USD 213,417	USD 84.15	USD 83.07
2025-11-03 (Monday)	197,609	USD 16,415,380	USD 16,415,380	USD 122,518	USD 83.07	USD 82.45
2025-10-31 (Friday)	197,609	USD 16,292,862	USD 16,292,862	USD -203,537	USD 82.45	USD 83.48
2025-10-30 (Thursday)	197,609	USD 16,496,399	USD 16,496,399	USD 156,111	USD 83.48	USD 82.69
2025-10-29 (Wednesday)	197,609	USD 16,340,288	USD 16,340,288	USD 98,804	USD 82.69	USD 82.19
2025-10-28 (Tuesday)	197,609	USD 16,241,484	USD 16,241,484	USD 270,725	USD 82.19	USD 80.82
2025-10-27 (Monday)	197,609	USD 15,970,759	USD 15,970,759	USD 932,714	USD 80.82	USD 76.1

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00BYZK4776

Show aggregate share trades of EW

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-24 SELL -1,674 76.100 77.160 77.054 USD -128,988 73.44 Loss of -6,051 on sale
2025-09-11 BUY 838 78.010 78.540 78.487 USD 65,772 73.12
2025-07-08 SELL -838 76.390 77.300 77.209 USD -64,701 72.61 Loss of -3,854 on sale
2025-06-24 SELL -834 75.850 76.630 76.552 USD -63,844 72.32 Loss of -3,528 on sale
2025-06-23 BUY 137 75.320 75.690 75.653 USD 10,364 72.30
2025-06-20 BUY 33,910 73.830 74.750 74.658 USD 2,531,653 72.29
2025-06-11 SELL -694 75.470 76.150 76.082 USD -52,801 72.16 Loss of -2,721 on sale
2025-05-30 SELL -694 78.220 78.300 78.292 USD -54,335 71.82 Loss of -4,494 on sale
2025-05-21 BUY 694 76.100 77.770 77.603 USD 53,856 71.57
2025-05-14 SELL -4,164 76.750 77.240 77.191 USD -321,423 71.36 Loss of -24,293 on sale
2025-04-30 SELL -694 75.490 76.350 76.264 USD -52,927 71.00 Loss of -3,656 on sale
2025-04-28 SELL -694 75.540 76.600 76.494 USD -53,087 70.90 Loss of -3,884 on sale
2025-04-25 SELL -694 76.040 76.100 76.094 USD -52,809 70.84 Loss of -3,643 on sale
2025-04-11 SELL -4,146 69.400 69.830 69.787 USD -289,337 70.80 Profit of 4,207 on sale
2025-04-08 SELL -2,073 67.070 70.780 70.409 USD -145,958 70.88 Profit of 985 on sale
2025-04-07 BUY 1,969 69.000 71.220 70.998 USD 139,795 70.91
2025-03-31 SELL -1,356 72.480 72.740 72.714 USD -98,600 70.88 Loss of -2,487 on sale
2025-03-21 SELL -1,356 70.460 70.940 70.892 USD -96,130 70.87 Loss of -33 on sale
2025-03-12 SELL -679 68.510 70.740 70.517 USD -47,881 70.98 Profit of 312 on sale
2025-02-28 SELL -679 71.620 71.770 71.755 USD -48,722 71.00 Loss of -512 on sale
2025-02-25 BUY 679 71.450 73.120 72.953 USD 49,535 70.97
2025-02-20 SELL -679 74.710 75.210 75.160 USD -51,034 70.83 Loss of -2,942 on sale
2025-02-19 BUY 1,358 74.670 76.500 76.317 USD 103,638 70.76
2025-02-18 BUY 679 75.670 76.670 76.570 USD 51,991 70.66
2024-12-30 BUY 1,150 74.240 75.350 75.239 USD 86,525 69.68
2024-12-06 SELL -668 71.530 73.740 73.519 USD -49,111 69.45 Loss of -2,715 on sale
2024-12-04 SELL -668 74.200 74.680 74.632 USD -49,854 69.18 Loss of -3,642 on sale
2024-12-03 SELL -1,336 70.200 70.570 70.533 USD -94,232 69.14 Loss of -1,859 on sale
2024-11-22 BUY 1,197 70.480 71.000 70.948 USD 84,925 68.37
2024-11-21 SELL -665 70.380 70.880 70.830 USD -47,102 68.27 Loss of -1,703 on sale
2024-11-20 SELL -659 69.540 70.610 70.503 USD -46,461 68.20 Loss of -1,518 on sale
2024-11-19 BUY 1,559 70.200 70.260 70.254 USD 109,526 68.08
2024-11-18 SELL -2,624 69.890 71.080 70.961 USD -186,202 67.97 Loss of -7,853 on sale
2024-11-12 SELL -656 65.810 66.790 66.692 USD -43,750 68.11 Profit of 932 on sale
2024-11-07 SELL -656 65.840 66.330 66.281 USD -43,480 68.43 Profit of 1,411 on sale
2024-11-05 SELL -1,312 66.690 66.720 66.717 USD -87,533 68.83 Profit of 2,777 on sale
2024-10-28 SELL -656 68.520 72.150 71.787 USD -47,092 69.93 Loss of -1,221 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-24	SELL	-1,674	76.100	77.160	77.054	USD -128,988	73.44 Loss of -6,051 on sale
2025-09-11	BUY	838	78.010	78.540	78.487	USD 65,772	73.12
2025-07-08	SELL	-838	76.390	77.300	77.209	USD -64,701	72.61 Loss of -3,854 on sale
2025-06-24	SELL	-834	75.850	76.630	76.552	USD -63,844	72.32 Loss of -3,528 on sale
2025-06-23	BUY	137	75.320	75.690	75.653	USD 10,364	72.30
2025-06-20	BUY	33,910	73.830	74.750	74.658	USD 2,531,653	72.29
2025-06-11	SELL	-694	75.470	76.150	76.082	USD -52,801	72.16 Loss of -2,721 on sale
2025-05-30	SELL	-694	78.220	78.300	78.292	USD -54,335	71.82 Loss of -4,494 on sale
2025-05-21	BUY	694	76.100	77.770	77.603	USD 53,856	71.57
2025-05-14	SELL	-4,164	76.750	77.240	77.191	USD -321,423	71.36 Loss of -24,293 on sale
2025-04-30	SELL	-694	75.490	76.350	76.264	USD -52,927	71.00 Loss of -3,656 on sale
2025-04-28	SELL	-694	75.540	76.600	76.494	USD -53,087	70.90 Loss of -3,884 on sale
2025-04-25	SELL	-694	76.040	76.100	76.094	USD -52,809	70.84 Loss of -3,643 on sale
2025-04-11	SELL	-4,146	69.400	69.830	69.787	USD -289,337	70.80 Profit of 4,207 on sale
2025-04-08	SELL	-2,073	67.070	70.780	70.409	USD -145,958	70.88 Profit of 985 on sale
2025-04-07	BUY	1,969	69.000	71.220	70.998	USD 139,795	70.91
2025-03-31	SELL	-1,356	72.480	72.740	72.714	USD -98,600	70.88 Loss of -2,487 on sale
2025-03-21	SELL	-1,356	70.460	70.940	70.892	USD -96,130	70.87 Loss of -33 on sale
2025-03-12	SELL	-679	68.510	70.740	70.517	USD -47,881	70.98 Profit of 312 on sale
2025-02-28	SELL	-679	71.620	71.770	71.755	USD -48,722	71.00 Loss of -512 on sale
2025-02-25	BUY	679	71.450	73.120	72.953	USD 49,535	70.97
2025-02-20	SELL	-679	74.710	75.210	75.160	USD -51,034	70.83 Loss of -2,942 on sale
2025-02-19	BUY	1,358	74.670	76.500	76.317	USD 103,638	70.76
2025-02-18	BUY	679	75.670	76.670	76.570	USD 51,991	70.66
2024-12-30	BUY	1,150	74.240	75.350	75.239	USD 86,525	69.68
2024-12-06	SELL	-668	71.530	73.740	73.519	USD -49,111	69.45 Loss of -2,715 on sale
2024-12-04	SELL	-668	74.200	74.680	74.632	USD -49,854	69.18 Loss of -3,642 on sale
2024-12-03	SELL	-1,336	70.200	70.570	70.533	USD -94,232	69.14 Loss of -1,859 on sale
2024-11-22	BUY	1,197	70.480	71.000	70.948	USD 84,925	68.37
2024-11-21	SELL	-665	70.380	70.880	70.830	USD -47,102	68.27 Loss of -1,703 on sale
2024-11-20	SELL	-659	69.540	70.610	70.503	USD -46,461	68.20 Loss of -1,518 on sale
2024-11-19	BUY	1,559	70.200	70.260	70.254	USD 109,526	68.08
2024-11-18	SELL	-2,624	69.890	71.080	70.961	USD -186,202	67.97 Loss of -7,853 on sale
2024-11-12	SELL	-656	65.810	66.790	66.692	USD -43,750	68.11 Profit of 932 on sale
2024-11-07	SELL	-656	65.840	66.330	66.281	USD -43,480	68.43 Profit of 1,411 on sale
2024-11-05	SELL	-1,312	66.690	66.720	66.717	USD -87,533	68.83 Profit of 2,777 on sale
2024-10-28	SELL	-656	68.520	72.150	71.787	USD -47,092	69.93 Loss of -1,221 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	406,402	0	1,881,727	21.6%
2025-09-18	684,520	1,177	3,487,981	19.6%
2025-09-17	484,322	210	1,603,065	30.2%
2025-09-16	811,953	856	2,055,937	39.5%
2025-09-15	611,012	104	1,391,882	43.9%
2025-09-12	982,928	1,100	2,234,227	44.0%
2025-09-11	514,234	828	1,919,009	26.8%
2025-09-10	669,705	149	1,567,941	42.7%
2025-09-09	441,493	0	925,375	47.7%
2025-09-08	632,587	672	1,251,939	50.5%
2025-09-05	334,037	300	934,006	35.8%
2025-09-04	380,318	0	871,931	43.6%
2025-09-03	701,943	459	1,170,966	59.9%
2025-09-02	397,396	53	1,208,872	32.9%
2025-08-29	397,628	800	844,318	47.1%
2025-08-28	604,087	4	1,056,653	57.2%
2025-08-27	493,608	822	875,886	56.4%
2025-08-26	480,268	0	868,213	55.3%
2025-08-25	796,556	0	1,181,258	67.4%
2025-08-22	552,739	1	1,011,678	54.6%
2025-08-21	873,044	798	1,597,742	54.6%
2025-08-20	847,847	38,699	1,560,105	54.3%
2025-08-19	613,349	33	1,256,577	48.8%
2025-08-18	668,719	439	1,642,759	40.7%
2025-08-15	369,455	513	826,723	44.7%
2025-08-14	514,202	6,112	864,593	59.5%
2025-08-13	567,857	299	1,347,264	42.1%
2025-08-12	547,773	12,316	1,428,277	38.4%
2025-08-11	487,823	0	1,152,630	42.3%
2025-08-08	661,697	20	1,224,458	54.0%
2025-08-07	669,931	982	1,297,469	51.6%
2025-08-06	880,028	413	1,551,659	56.7%
2025-08-05	661,933	8	1,592,649	41.6%
2025-08-04	572,165	268	1,310,044	43.7%
2025-08-01	678,028	5,600	1,308,863	51.8%
2025-07-31	831,401	249	1,817,975	45.7%
2025-07-30	1,305,016	693	2,481,808	52.6%
2025-07-29	1,129,154	58	2,399,223	47.1%
2025-07-28	684,101	2,111	2,276,892	30.0%
2025-07-25	1,669,752	920	6,616,259	25.2%
2025-07-24	455,593	0	2,607,898	17.5%
2025-07-23	444,645	0	1,978,110	22.5%
2025-07-22	447,883	511	2,702,925	16.6%
2025-07-21	568,293	27	1,249,727	45.5%
2025-07-18	590,448	59	2,118,402	27.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE